Vera Therapeutics, Inc.·4

May 26, 4:16 PM ET

Hall Kimball 4

4 · Vera Therapeutics, Inc. · Filed May 26, 2022

Insider Transaction Report

Form 4
Period: 2022-05-24
Hall Kimball
Director
Transactions
  • Award

    Stock Option (right to buy)

    2022-05-24+9,9259,925 total
    Exercise: $16.14Exp: 2032-05-23Class A Common Stock (9,925 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION